WASHINGTON, D.C. — The Centers for Disease Control and Prevention announced a $100 million grant package for states to strengthen measles surveillance and immunisation programmes as reported cases rise to a three‑year high.

The funding, distributed through the CDC’s Epidemic Preparedness Fund, will be allocated to 32 states that have reported at least one confirmed case since the start of the year. Federal officials said the cash infusion is intended to cover outreach campaigns, mobile clinics and data‑management tools, with an initial disbursement of $25 million slated for June.

Public‑health economists note that the investment could have ripple effects on the broader health‑care market. “When vaccination rates improve, we see a downstream reduction in hospital admissions and a stabilisation of demand for antiviral therapies,” said Dr. Lena Ortiz, senior analyst at Global Health Insights. Pharmaceutical firms that manufacture MMR vaccines are watching the rollout closely, as higher uptake may boost quarterly revenues by an estimated 3‑4 percent.

CDC Director Dr. Mandy Cohen emphasised the urgency, stating, “Measles is a preventable disease, yet we are seeing clusters in communities with low vaccination coverage, some as low as 78 percent compared with the 95 percent threshold for herd immunity.” State health commissioner James Patel of Arizona added, “These federal resources will help us close gaps in school‑based reporting and fund rapid response teams to contain outbreaks before they spread across borders.”

Investors are also weighing the policy shift. Shares of vaccine manufacturers such as Merck & Co. and GlaxoSmithKline edged up 1.2 percent in early trading, reflecting market optimism that increased government spending could translate into larger procurement contracts. Meanwhile, insurers are reassessing risk models for paediatric care, anticipating lower claim volumes if immunisation rates climb.

Key Takeaways

• The CDC is providing $100 million to 32 states to boost measles vaccination and case tracking.
• Measles cases in the United States have climbed to 2,517 this year, the highest count since 2019.
• Improved vaccination coverage could benefit vaccine makers and reduce health‑care costs linked to outbreak response.

As the funding is rolled out over the next 12 months, state officials will be required to submit quarterly progress reports, allowing the federal government to monitor the impact on vaccination rates and outbreak containment. The initiative underscores a broader policy focus on preventing vaccine‑preventable diseases before they threaten public health and economic stability.